Hematocrit stability following intravenous versus subcutaneous administration of epoetin alfa to dialysis patients: A post hoc analysis

Clinical Nephrology

Volumn 51, Issue 6, 1999, Pages 367-372

  Goodkin, D A ^a   Gimenez, L F ^b   Graber, S E ^c   Van Stone, J C ^d   Egrie, J C ^a   Okamoto, D M ^a  

^a AMGEN INC   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d University of Missouri   (United States)

Author keywords

Anemia; Epoetin alfa; Erythropoietin; Hematocrit; Hemodialysis route of administration

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; DATA BASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL AVAILABILITY; EPOETIN ALFA; HEMATINICS; HEMATOCRIT; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; RENAL DIALYSIS;

EID: 0033018897     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ariza-Andraca CR, Altamirano-Bustamante E, Frati-Munari AC, Altamirano-Bustamante P, Graef-Sanchez A 1991 Delayed insulin absorption due to subcutaneous edema. Arch Invest Med 22: 229-233
2. Beshyah SA, Anyaoku V, Niththyananthan R, Sharp P, Johnston DG 1991 The effect of subcutaneous injection site on absorption of human growth hormone: abdomen versus thigh. Clin Endocrinol 35: 409-412
3. Binder C 1969 Absorption of injected insulin. Acta Pharmacol Toxicol 27: 1-87
4. Collins A, Ma J, Keane W 1997 Hematocrit stability is associated with improved patient survival. Nephrol Dial Transplant 12: A 133
5. de Meijer PHEM, Lutterman JA, van Lier HJJ, van't Laar A 1990 The variability of the absorption of subcutaneously injected insulin: effect of injection technique and relation with brittleness. Diabet Med 7: 499-505
6. Ferrannini E, Linde B, Faber O 1982 Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subject. Clin Physiol 2: 59-70
7. Frid A, Linde B 1993 Clinically important differences in insulin absorption from abdomen in IDDM. Diabetes Res Clin Pract 21: 137-141
8. Galloway JA, Spradlin CT, Nelson RL et al 1981 Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care 4: 366-376
9. Halstenson CE, Macres M, Katz SA et al 1991 Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta. Clin Pharmacol Ther 50: 702-712
10. Hildebrandt P, Birch K, Sestoft L, Nielsen SL 1985 Orthostatic changes in subcutaneous blood flow and insulin absorption. Diabetes Res 2: 187-190
11. Hildebrandt P 1991a Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients. Acta Physiol Scand 143: 41-45
12. Hildebrandt P 1991b Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Dan Med Bull 38: 337-346
13. Home PD, Massi-Benedetti M, Gill GV et al 1982 Impaired subcutaneous absorption of insulin in "brittle" diabetes. Acta Endocrinol 101: 414-420
14. Jensen JD, Madsen JK, Jensen LW, Pedersen EB 1994 Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers. J Am Soc Nephrol 5: 177-185
15. Kolendorf K, Bojsen J, Nielsen SL 1979 Adipose tissue blood flow and insulin disappearance from subcutaneous tissue. Clin Pharmacol Ther 25: 598-604
16. 125I-NPH insulin in diabetic patients. Horm Metab Res 15: 274-278
17. Kroon C, De Boer A, Kroon JM, et al 1991 Influence of skinfold thickness on heparin absorption. Lancet 337: 945-946
18. Macdougall IC, Jones JM, Robinson MI et al 1991 Subcutaneous erythropoietin therapy: comparison of three different sites of injection. In: Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L (eds) Erythropoietin in Renal and Non-Renal Anemias. Contrib Nephrol 88: 152-156
19. Paganini EP, Eschbach JW, Lazarus JM et al 1995 Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patients. Am J Kidney Dis 26: 331-340
20. Paulsen EP, Courtney JW, Duckworth WC 1979 Insulin resistance caused by massive degradation of subcutaneous insulin. Diabetes 28: 640-645
21. Salmonson T, Danielson BG, Wikstrom B 1990 The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br J Clin Pharmacol 29: 709-713
22. Sindelka G, Heinemann L, Berger M, Frenck W, Chantelau E 1994 Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia 37: 377-380
23. Thow JC, Johnson AB, Marsden S, Taylor R, Home PD 1990 Morphology of palpably abnormal injection sites and effects on absorption of isophane (NPH) insulin. Diabet Med 7: 795-799
24. Veenstra J, van der Hulst JP, Wildenborg IH et al 1991 Effect of antihypertensive drugs on insulin absorption. Diabetes Care 14: 1089-1092
25. Vora JP, Burch A, Peters JR, Owens DR 1993 Absorption of radiolabelled soluble insulin in Type 1 (Insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry. Diabet Med 10: 736-743